profusa

Profusa is a biotechnology company headquartered in South San Francisco, California, that specializes in developing diagnostic solutions for blood clotting disorders and related conditions. Founded in 2008, the company focuses on creating innovative technologies to improve the monitoring and management of coagulation disorders, particularly those affecting patients undergoing anticoagulant therapy.

The company's primary technology platform involves biosensors and monitoring devices designed to provide real-time assessment of blood coagulation status. Their flagship product, the ProTime system, represents a significant advancement in point-of-care testing for patients taking warfarin and other anticoagulant medications. This system allows for more frequent and convenient monitoring compared to traditional laboratory-based testing methods.

Profusa's technology utilizes proprietary hydrogel-based biosensors that can be implanted subcutaneously to continuously monitor various biomarkers related to blood coagulation. These sensors are designed to provide healthcare providers with real-time data, enabling more precise dosing of anticoagulant medications and potentially reducing the risk of complications such as bleeding or thrombosis.

The company has received significant investment from venture capital firms and strategic partners in the medical device industry. Profusa has also established partnerships with major pharmaceutical companies to integrate their monitoring technologies with anticoagulant drug therapies.

Profusa's innovations address a critical need in modern medicine, as blood clotting disorders affect millions of people worldwide. Traditional monitoring methods often require frequent blood draws and laboratory visits, which can be inconvenient for patients and may not provide timely information for optimal treatment adjustments. The company's approach aims to make coagulation monitoring more accessible, accurate, and patient-friendly.

The company continues to expand its product portfolio and research initiatives, with ongoing development of additional biosensor applications for various medical conditions beyond coagulation disorders. Profusa's work represents part of the broader trend toward personalized medicine and continuous health monitoring through advanced biosensor technology.